Terry Moy

Terry (Terence) Moy has had an extensive work experience in various scientific roles. Terry (Terence) currently holds the position of Director of Screening Biology at Morphic Therapeutic since January 2024. Prior to this, they worked as Associate Director and Principal Scientist at the same company from 2018 to 2023 and 2018 to 2021, respectively. Terry (Terence) also served as a Senior Scientist from August 2015 to December 2017.

Before joining Morphic Therapeutic, Terry worked at Cubist Pharmaceuticals as a Scientist II from January 2011 to May 2015, and as a Scientist I from December 2007 to December 2010. Preceding their time at Cubist Pharmaceuticals, Terry held the role of Postdoctoral Research Fellow at the Broad Institute in 2006, and as a Postdoctoral Research Fellow at Massachusetts General Hospital from 2002 to 2007.

Their work experience also includes being a Graduate Student and Postdoctoral Fellow at Harvard Medical School from 1996 to 2007, a Graduate Student at Dana-Farber Cancer Institute from 1997 to 2001, and a Research Technician at Northwestern University from December 1995 to June 1996.

Terry (Terence) Moy completed a B.A. in Molecular & Cellular Biology at Northwestern University from 1992 to 1995. Subsequently, they pursued a Ph.D. in Cell Biology at Harvard University from 1996 to 2001.